Two Sigma Investments’s DiaMedica Therapeutics DMAC Stock Holding History

Two Sigma Investments’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,149	Closed	-$19.2K	–	3009
2022 Q4	$19.2K	Sell	12,149 -2,369	-16%	-$3.19K	﹤0.01%	2682
2022 Q3	$18K	Sell	14,518 -2,731	-16%	-$4.27K	﹤0.01%	2386
2022 Q2	$35K	Sell	17,249 -32,819	-66%	-$76.6K	﹤0.01%	2369
2022 Q1	$125K	Sell	50,068 -90,789	-64%	-$258K	﹤0.01%	2408
2021 Q4	$525K	Buy	140,857 +66,577	+90%	+$261K	﹤0.01%	3209
2021 Q3	$298K	Buy	+74,280	New	+$284K	﹤0.01%	3675

Other funds holding DMAC

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments's DMAC Position: Q1 2023 in Review

Two Sigma Investments sold out of DiaMedica Therapeutics (DMAC) in Q1 2023, closing a stake of 12,149 shares — an estimated $19.2K sold.

Two Sigma Investments first reported a position in DMAC in Q3 2021 and held it in 6 quarters. The position peaked at $525K in Q4 2021. 25 funds tracked by Wall St. Rank hold DMAC as of Q1 2023.

Two Sigma Investments reported no remaining DiaMedica Therapeutics position as of Q1 2023 after selling out during the quarter.
Two Sigma Investments sold 12,149 DiaMedica Therapeutics shares in Q1 2023, an estimated $19.2K.
Two Sigma Investments first reported a position in DiaMedica Therapeutics in Q3 2021 and held it in 6 quarters.
Two Sigma Investments's DiaMedica Therapeutics position peaked at $525K in Q4 2021.
25 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2023.

Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.